Abcellera Biologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adicet Bio (NASDAQ:ACET – Get Free Report) and AbCellera Biologics (NASDAQ:ABCL – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 85.3% of Adicet […]

AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Research analysts at Bloom Burton boosted their Q3 2023 EPS estimates for AbCellera Biologics in a research report issued on Monday, August 7th. Bloom Burton analyst A. Borovina now expects that the company will earn ($0.12) per share for the quarter, up from their previous estimate of […]

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) and AbCellera Biologics (NASDAQ:ABCL – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Profitability This table compares Ironwood Pharmaceuticals and AbCellera Biologics’ net […]

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) and AbCellera Biologics (NASDAQ:ABCL – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation. Analyst Recommendations This is a breakdown of current ratings for […]

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Rating) – Stock analysts at SVB Leerink upped their Q1 2023 EPS estimates for AbCellera Biologics in a report released on Thursday, April 20th. SVB Leerink analyst P. Souda now anticipates that the company will earn ($0.09) per share for the quarter, up from their previous estimate of ($0.13). […]